Andy Pasternak - 12 Jun 2025 Form 4 Insider Report for Context Therapeutics Inc. (CNTX)

Role
Director
Signature
/s/ Alex Levit, Attorney-in-Fact
Issuer symbol
CNTX
Transactions as of
12 Jun 2025
Transactions value $
$0
Form type
4
Filing time
12 Jun 2025, 17:30:09 UTC
Previous filing
14 Jan 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Pasternak Andy Director 2001 MARKET STREET, SUITE 3915 UNIT #15, PHILADELPHIA /s/ Alex Levit, Attorney-in-Fact 12 Jun 2025 0001792746

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNTX Stock Option (right to buy) Award $0 +138,900 $0.000000 138,900 12 Jun 2025 Common Stock 138,900 $0.6530 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable on the earlier of (i) June 12, 2026 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2026 annual meeting of stockholders, subject to continued service with the Issuer.